| 1 | jobs at irish sites | | | | | | | 2 | 0.42% |
| 2 | life science industry awards | | | | | | | 2 | 0.42% |
| 3 | pharma industry awards ie | | | | | | | 2 | 0.42% |
| 4 | cut more than 200 | | | | | | | 2 | 0.42% |
| 5 | to cut more than | | | | | | | 2 | 0.42% |
| 6 | pharma industry awards uk | | | | | | | 2 | 0.42% |
| 7 | significant reskilling needed for | | | | | | | 2 | 0.42% |
| 8 | reskilling needed for ireland’s | | | | | | | 2 | 0.42% |
| 9 | pfizer to cut more | | | | | | | 2 | 0.42% |
| 10 | senior hires in public | | | | | | | 1 | 0.21% |
| 11 | two senior hires in | | | | | | | 1 | 0.21% |
| 12 | announces two senior hires | | | | | | | 1 | 0.21% |
| 13 | lilly announces two senior | | | | | | | 1 | 0.21% |
| 14 | eli lilly announces two | | | | | | | 1 | 0.21% |
| 15 | transform health and care? | | | | | | | 1 | 0.21% |
| 16 | labour government transform health | | | | | | | 1 | 0.21% |
| 17 | government transform health and | | | | | | | 1 | 0.21% |
| 18 | in public affairs and | | | | | | | 1 | 0.21% |
| 19 | uk’s labour government transform | | | | | | | 1 | 0.21% |
| 20 | the uk’s labour government | | | | | | | 1 | 0.21% |
| 21 | can the uk’s labour | | | | | | | 1 | 0.21% |
| 22 | how can the uk’s | | | | | | | 1 | 0.21% |
| 23 | the first 1tn drugmaker? | | | | | | | 1 | 0.21% |
| 24 | become the first 1tn | | | | | | | 1 | 0.21% |
| 25 | lilly become the first | | | | | | | 1 | 0.21% |
| 26 | eli lilly become the | | | | | | | 1 | 0.21% |
| 27 | can eli lilly become | | | | | | | 1 | 0.21% |
| 28 | advance huntington’s disease therapy | | | | | | | 1 | 0.21% |
| 29 | hires in public affairs | | | | | | | 1 | 0.21% |
| 30 | 2024 all rights reserved | | | | | | | 1 | 0.21% |
| 31 | 5 fda decisions to | | | | | | | 1 | 0.21% |
| 32 | valerio therapeutics announces acquisition | | | | | | | 1 | 0.21% |
| 33 | bridge ai technology and | | | | | | | 1 | 0.21% |
| 34 | to bridge ai technology | | | | | | | 1 | 0.21% |
| 35 | established to bridge ai | | | | | | | 1 | 0.21% |
| 36 | center established to bridge | | | | | | | 1 | 0.21% |
| 37 | new center established to | | | | | | | 1 | 0.21% |
| 38 | acquisition of emglev therapeutics | | | | | | | 1 | 0.21% |
| 39 | announces acquisition of emglev | | | | | | | 1 | 0.21% |
| 40 | therapeutics announces acquisition of | | | | | | | 1 | 0.21% |